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Abstract. A one-step enzymatic reaction for improving the collision-induced
dissociation (CID)-based tandem mass spectrometry (MS/MS) analysis of
phosphorylated peptides in an ion trap is presented. Carboxypeptidase-B (CBP-
B) was used to selectively remove C-terminal arginine or lysine residues from
phosphorylated tryptic/Lys-C peptides prior to their MS/MS analysis by CID with a
Paul-type ion trap. Removal of this basic C-terminal residue served to limit the
extent of gas-phase neutral loss of phosphoric acid (H
3
PO
4
), favoring the
formation of diagnostic b and y ions as determined by an increase in both the
number and relative intensities of the sequence-specific product ions. Such
differential fragmentation is particularly valuable when the H
3
PO
4
elimination is so
predominant that localizing the phosphorylation site on the peptide sequence is hindered. Improvement in
the quality of tandem mass spectral data generated by CID upon CBP-B treatment resulted in greater
confidence both in assignment of the phosphopeptide primary sequence and for pinpointing the site of
phosphorylation. Higher Mascot ion scores were also generated, combined with lower expectation values
and higher delta scores for improved confidence in site assignment; Ascore values also improved. These
results are rationalized in accordance with the accepted mechanisms for the elimination of H
3
PO
4
upon low
energy CID and insights into the factors dictating the observed dissociation pathways are presented. We
anticipate this approach will be of utility in the MS analysis of phosphorylated peptides, especially when
alternative electron-driven fragmentation techniques are not available.
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Introduction
Protein phosphorylation is a particularly prevalent post-translational modification (PTM), having critical
regulatory roles in most cellular signaling systems [1]. Mass
spectrometry (MS) has become the technique of choice for the
qualitative [2] and quantitative [3–5] study of protein
phosphorylation because of its unparalleled versatility and
sensitivity. ‘Bottom-up’ phosphoproteomics analysis takes
place at the peptide-level and usually requires phosphopeptide
enrichment [6–8] because of the generally sub-stoichiometric
levels of phosphorylated peptides relative to their non-modified
counterparts [9] and their somewhat reduced ionization
efficiency [10, 11], both factors that are detrimental in data-
dependent analysis (DDA) strategies where the selection and
fragmentation of precursor ions is dictated by their relative
intensities.
The sequence and exact site(s) of phosphorylation are
routinely determined by fragmenting the precursor ions using a
range of techniques, with collision-induced dissociation (CID)
still being the most widely used [12, 13]. During CID,
unmodified peptides undergo facile cleavage of the amidic
C–N bond, generating b and y ions in accordance with the
mobile proton model [14–17]. The presence of a labile
functional group, such as an O-phosphoester on the peptide,
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dramatically changes its fragmentation pathways under CID
conditions. Owing to the slow heating nature of CID, as
experienced particularly with ion trap instruments, the pathway
characterized by the most easily accessible energetic profile
will be favored, and the balance between different dissociation
channels will be dictated by their relative energetic demands
[13, 18–22]. Phosphorylated peptides undergo facile loss of
H3PO4 during CID, to an extent which is ultimately dependent
on the mobility of the ionizing proton(s), dictated by the ratio
between the number of basic residues and the charge state of
the observed ion [13, 20, 21]. The extent of neutral loss is
generally greater with ion trap mass spectrometers compared
with ‘tandem-in-space’ instruments (e.g., Q-ToFs) [23], mainly
because of the difference in the amount of energy deposited in
the precursor ion and the time involved in the energy transfer
[24]. When the number of ionizing protons is larger than the
number of basic residues, the peptide ion is believed to be
under a mobile proton environment (MPE) [13, 20], where the
ionizing proton(s) can be easily relocated and randomized over
several amide nitrogen atoms. Relocation of these protons
directs C–N bond dissociation and balances the competition
between backbone cleavage of the modified peptide and the
elimination of H3PO4 [20]. In a limited proton mobility
environment (LPME), the neutral loss pathway is characterized
by considerably smaller bond dissociation energies than those
associated with cleavage of the amide bond and can therefore
become predominant [20]. The C-termini of tryptic (and Lys-
C) peptides can act as proton ‘sinks’, trapping the ionizing
protons because of their high proton affinity, thereby resulting
in a more LPME and favoring the gas-phase elimination of
phosphoric acid over the C–N bond dissociation. Although
several mechanisms have been suggested for the elimination of
H3PO4, charge-directed intramolecular nucleophilic
substitution (SN2) reactions are characterized by the lowest
energetic demands and are, therefore, prevalent (Scheme 1 and
Supplementary Scheme 1) [13, 20, 21].
Under MPE, one of the ionizing protons can be relocated
on the sp2 oxygen of the phosphate, thus inducing the
formation of a more electrophilic β-carbon atom, which can
then undergo a SN2 reaction (Scheme 1a). In the LPME, it is
the interaction between the protonated side chain of an
arginine (or lysine) residue and the phosphate that plays a
major role in dictating the outcome of the CID (Scheme 1b).
This interaction, reported as a particularly strong ionic
hydrogen bond [25], facilitates the transfer of a proton from
the C-terminal residue to that which is phosphorylated. This
results in a lower activation barrier of the process, which
would otherwise be considerably higher because of the much
greater proton affinity (PA) of Arg (PA = 251.2 kcal/mol)
[26] and Lys (PA = 239.4 kcal/mol) [26], compared with
phosphorylated Ser (PA = 224.2 kcal/mol) [27] and
phosphorylated Thr (PA = 224.8 kcal/mol) [27]. The
interplay between the different mechanisms is mainly
dictated by the charge state and the primary and secondary
structures of the gas-phase peptide ions [13, 20]. The role
played by basic residues in the product ions generated
following CID of a phosphorylated peptide has recently been
readdressed by Laskin et al. [28] using energy-resolved
surface-induced dissociation (SID) experiments on the
model phosphorylated peptide (R/K)GGGpSGGG. These
authors concluded that neutral loss of H3PO4 occurs via a
two-step process, which involves abstraction of the
phosphate to form an ion-molecule complex, whose
dissociation eventually leads to the neutral loss product ion
and neutral (meta)phosphoric acid.
The formation of a strong hydrogen bond between a
protonated arginine residue and the phosphate has also been
reported to be responsible for the gas-phase rearrangement
of phosphate observed to different extents in the CID of
tryptic peptides, especially under LPME [25].
A considerable amount of research has been devoted to
improving the tandem MS analysis of phosphorylated
peptides, mainly looking at derivatization reactions aimed
at manipulating the physical chemical properties
phosphorylated peptides and thereby improving their
ionization efficiency and fragmentation [29]. Gas-phase
ion–molecule reactions using trivalent boron species have
also been exploited to modulate the collisional dissociation
behavior of simple model phosphorylated peptides in a
quadrupole ion trap [30], showing a partial reduction of
H3PO4 elimination of the derivatized peptides.
Owing to their purportedly nonergodic nature [31],
electron-driven strategies such as electron transfer
dissociation (ETD) and electron capture dissociation (ECD)
are generally believed to outperform CID for determining
sites of covalent modifications [32], but they are not always
implemented on commercially available instrumental
platforms. Moreover, fragmentation efficiencies are
largely dependent on the charge state or, more
appropriately, charge density of the precursor ion [33,
34]. MS analysis of modified peptides therefore still
largely relies on collisional dissociation, and a strategy
able to modify the dissociation features of these species
to favor the formation of more sequence diagnostic ions
would be of significant benefit.
Here we describe the enzymatic removal of the C-
terminal basic residue of tryptic and/or Lys-C
phosphorylated peptides with carboxypeptidase-B (CBP-B),
which effectively removes the C-terminal proton ‘sink’,
releasing the ionizing proton(s). CBP-B treatment thereby
overcomes the problems associated with predominant loss of
H3PO4 and improves the quality of CID product ion mass
spectra for phosphopeptide identification. This procedure
can be performed in the same buffer conditions as most
standard proteases and, therefore, does not require additional
clean-up steps. The use of alternative or complementary
proteases in the bottom-up MS analysis of peptides is not
unprecedented [35, 36], and we ourselves have shown utility
of CBP-B in manipulating peptide dissociation by both CID
and ETD [37]. Ultimately, this study demonstrates
significant benefits of CBP-B treatment for enhanced
analysis of phosphopeptides by CID-MS/MS.
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Experimental
Sample Preparation
Synthetic phosphorylated peptides were obtained from
Intavis AG (Köln, Germany) and diluted to a final
concentration of 1 pmol/μL in 3 % (vol/vol) MeCN, 0.1 %
(vol/vol) TFA.
An equimolar mixture of α-casein (comprising α-S1-casein,
α-S2-casein), β-casein (Sigma Aldrich, Gillingham, Dorset,
UK), and Aurora A [38] was diluted to a final concentration of
1 μg/μL in 50 mMNH4HCO3. Disulphide bonds were reduced
with 4.2 mM dithiothreitol (DTT) for 10 min at 60 °C. Samples
were cooled to room temperature and alkylated with 16 mM
iodoacetamide (IAA) for 45 min in the dark at room
temperature. Excess IAA was quenched by addition of DTT
to a final concentration of 8 mM. Proteins were digested with
either trypsin or Lys-C (Roche, Hertfordshire, UK) (1:50
enzyme:protein) at 37 °C overnight.
Peptide mixtures (trypsin or Lys-C generated) were
incubated with CBP-B (Worthington Biochemicals, Lakewood
Township, NJ, USA) (12 units/mg protein) at room temperature
for 2 h. An aliquot of the digestion solutions (before or after
CBP-B treatment) was diluted in 0.1 % (vol/vol) TFA to a final
concentration of 100 fmol/μL and analyzed by nanoflow-ultra
high performance liquid chromatography-electrospray-tandem
mass spectrometry (nUHPLC-ESI-MS/MS).
Liquid Chromatography and Mass Spectrometry
Data-dependent n-UHPLC-ESI-MS/MS analyses were
performed using a Bruker amaZon ETD ion trap MS
arranged in-line with a Thermo Scientific Ultimate 3000
nanoflow n-UHPLC system™, using CID as the activation
technique (see Supplementary Method for details). Peaklists
from the CID MS/MS spectra were extracted using Data
Analysis software 4.0 (Bruker, Bremen, Germany) and
converted to Mascot generic files (.mgf).
Database Searching and Data Analysis
.mgf files were searched against the concatenated SwissProt
database (2011.05.03) using the Mascot search engine
(2.2.06), specifying either H. sapiens or other mammalia
for taxonomy as appropriate. Precursor mass tolerance was
set to 0.4 Da and fragment ion tolerance to 0.6 Da. Up to 1
missed cleavage was permitted. Trypsin, Lys-C, trypsin/
CBP-B, and Lys-C/CBP-B were selected as the enzyme(s)
depending on the combination of proteases used. CBP-B
cleavage was defined as cleavage N-terminal to K/R.
Carbamidomethylation of Cys was set as a fixed
modification. Deamidation of Asn and Gln, oxidation of
Met, and phosphorylation of Ser, Thr, and Tyr were set as
variable modifications. The completeness of the CBP-B
treatment as well as the effect of the treatment on the
ionization efficiency of the phosphorylated peptides were
assessed by comparing the peak areas of extracted ion
chromatograms (XIC) of the corresponding protonated
peptides before and after the treatment (Supplementary
Tables 1 and 2). As the purpose of the Mascot search was
to show an increased performance of the search engine
before and after the treatment, all of the peptides identified
as phosphorylated were retained, and the associated CID
tandem mass spectra were manually inspected. As for the
non-modified peptides, a minimum Mascot ion score of 25
was required for them to be included in Supplementary
Table 1.
Quantification of Product Ion Currents
To quantify relative product ion currents, an in-house R
script was developed. Peak lists corresponding to the peptide
(a)
(b)
Scheme 1. Proposed pathways for the elimination of H3PO4 from a phosphorylated peptide in a (a) mobile proton or (b)
limited proton mobility environment. (a) Intramolecular nucleophilic substitution (SN2) reactions invoked under a mobile proton
environment (MPE); (b) charge directed intramolecular nucleophilic substitution (SN2) reaction involving formation of a hydrogen
bond between a protonated guanidinium side chain and the phosphate group
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spectral matches were extracted using the following
characteristic identifiers: file name, elution time, m/z ratio,
and charge state of precursor ion, and annotated according to
the highest-scoring sequences identified by Mascot and
validated by manual inspection of the corresponding CID
product ion mass spectra. Theoretical product ions
considered included neutral loss of H3PO4 and H2O from
the precursor ion, b and y ions ± loss of H3PO4, and b and y
ions ± loss of H2O or NH3 as appropriate, with charge state
≤ +2. The relative product ion current (defined here as the
summation of ion current within a given category against the
total ion current) was then computed.
Computational Phosphorylation Site Localization
Mascot Delta score (MD) [39] and Ascore [40] were
employed as scoring measures to assess confidence in
phosphosite localization. MD values were computed
manually from the Mascot output. Ascore values were
determined post-database search, using the identified
phosphopeptides from Mascot and extracting their
corresponding MS/MS as input for the Ascore webserver
(http://ascore.med.harvard.edu/ascore.html).
Results and Discussion
Reduced Elimination of H3PO4 with CBP-B
Treatment and Enhanced Formation
of Sequence-Specific Product Ions
It was our hypothesis that removal of the C-terminal basic
residue, which plays a fundamental role in the gas-phase
dissociation of phosphorylated peptides by facilitating the
H3PO4 elimination pathway [20, 21, 25], should result in an
increase in the number and relative intensity of diagnostic b
and y ions and thereby improve the quality of the CID
product ion mass spectra. In an attempt to develop a fast,
one-step protocol to alter the gas-phase behavior of
protonated phosphopeptide ions, the C-terminal basic
residue (arginine or lysine) was removed from tryptic/Lys-
C generated phosphorylated peptides with a simple
enzymatic reaction using CBP-B, which catalyzes the
hydrolysis of basic amino acids from the C-terminal position
of a polypeptide. Based on current understanding of the
mechanisms of dissociation of phosphorylated peptides,
removal of this residue should balance the competition
between elimination of phosphoric acid and cleavage of the
amidic C–N bond.
To test our hypothesis, we assessed the effect of CBP-B
treatment on a mixture of phosphorylated proteins after
digestion with either trypsin or Lys-C. Twenty-four peptides
from the digested mixture of proteins (66 % of the total
peptide number) were observed as their cognate CBP-B
analogues, with the C-terminal arginine or lysine residue
having been removed (Supplementary Table 1). All of the
phosphopeptides identified prior to CBP-B treatment wereT
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converted into their CBP-B analogues. Four further
phosphorylated peptides (DIGSEpSTEDQAMEDI,
DIGpSEpSTEDQAMEDI, QLQApTSVPHPVS, and
RpTpTLCGTLDYLPPEMIEG) were also identified after
treatment (Table 1 and Supplementary Table 1), in addition
to a further nine non-phosphorylated peptides. The
efficiency of the enzymatic reaction with CBP-B, monitored
by measuring the peak areas of the extracted ion
chromatograms (XICs) associated with the native and
CBP-B treated peptides, was close to 100 % for most of
the identified peptides, with limited residual tryptic or Lys-C
peptides found in the treated samples. Three of the
phosphorylated species showed incomplete conversion,
varying from 40 % (FQpSEEQQQTEDELQDK) to 62 %
(TVDMEpSTEVFTK) and 82 % (VPQLEIVPNpSAEER)
(Supplementary Table 1). Interestingly, the same rate of
incomplete CBP-B conversion was also observed for the
non-phosphorylated form of TVDMEpSTEVFTK,
suggesting that proteolytic efficiency may be sequence-
dependent.
The charge states in which the untreated and treated
peptides were observed were also comparable for the two
sample sets, although unsurprisingly there was a reduction in
the number of treated peptides that were further observed as
triply charged species: 25 % untreated peptides were
observed as triply charged species, which reduced to 8 %
for the CBP-B peptides (Supplementary Table 1). No singly
charged peptides could be identified under our instrumental
conditions before or after the treatment, even when singly
charged ions were included in the precursor ion selection.
The ionization efficiency of the phosphorylated peptides
showed a sequence-dependent response to the treatment,
ranging from increased relative signal intensity of 2.7-fold
for VLVpTQQFPCQNPLPVNSGQAQ(R), to 0.4 for
LVpSSHKPVQNQ(K) (Supplementary Table 2), suggesting
a more complex scenario than one would envisage for the
relationship between the presence of a C-terminal basic
residue and the efficiency of ESI.
Comparison of the CID product ion mass spectra of the
nine phosphorylated peptide pairs listed in Table 2A and B,
before and after CBP-B treatment, indicated that the effects
of removal of the C-terminal basic residue can be divided
into three main groups: (1) absence of neutral loss of H3PO4
and the concurrent enhanced formation of b and y ions; (2)
substantial reduction in the extent of neutral loss; (3) no
change in the predominance of neutral loss attributable to the
presence of internal basic residues, examples of which will
be presented.
The CID product ion mass spectrum of the untreated
peptide VLVpTQQFPCQNPLPVNSGQAQR (Figure 1a) is
dominated by the peaks corresponding to loss of H3PO4 (m/z
1231.7) and (H3PO4 + H2O) (m/z 1222.7).
However, the corresponding CBP-B treated peptide
VLVpTQQFPCQNPLPVNSGQAQ (Figure 1b) clearly
shows how removal of the C-terminal basic residue results
in complete absence of neutral loss product ions; a dramatic
improvement in the formation of diagnostic b and y ions was
observed, leading to an almost complete generation of
sequence determining ions. Some relatively intense ions
were also present in both the treated and untreated spectra,
which could not be assigned based on the known sequence
of the peptide. Of particular interest are the diagnostic ions
y17
2+ (at low intensity) and y18
2+, which were observed
following CBP-B treatment, allowing unambiguous
assignment of the phosphorylation site at position Thr4.
Assignment of the modification site in the CID product ion
mass spectrum of the untreated peptide is indirect, relying
primarily on observation of loss of H3PO4 from a limited
Table 2. Percentages of Ion Currents Related to: Neutral loss of H3PO4 (−H2O) from the Precursor Ion; Intact, Singly and Doubly Charged b and y Ions;
Neutral Loss of H3PO4 from Singly and Doubly Charged b (Δb) and y (Δy) Ions
Peptide M-H3PO4 (−H2O) b ions y ions Δb ions Δy ions Sequence-specific ions
VPQLEIVPNpSAEER 30.1 29.3 34.3 1.9 4.2 21
FQpSEEQQQTEDELQDK 39.8 10.8 35.1 13.8 0.5 28
EQLSTpSEENSK 38.9 4.2 56.9 0 0 10
TVDMEpSTEVFTK 72.1 4.6 12.6 3.3 7.4 23
TVDMEpSTEVFTKK 65.9 8.3 19.3 5.3 1.2 14
VLCPSNpSSQR 35.7 11.0 35.2 5.5 12.6 11
LVpSSHKPVQNQK 84.9 3.2 8.8 2.6 0.4 16
VLVpTQQFPCQNPLPVNSGQAQR 47.9 11.7 16.8 16.1 7.4 16
ILSDVTHpSAVFGVPASK 35.9 24.7 33.2 6.1 0 17
VPQLEIVPNpSAEE 2.2 50.5 46.1 0.6 0.5 18
FQpSEEQQQTEDELQD 11.1 39.6 29.0 20.2 0.7 31
EQLSTpSEENS 39.7 32.7 22.2 3.8 2.1 22
TVDMEpSTEVFT 8.5 70.4 20.7 0 0.3 22
VLCPSNpSSQ 45.8 26.5 21.9 1.8 4.0 16
LVpSSHKPVQNQ 68.0 4.8 10.9 8.8 7.4 18
DIGSEpSTEDQAMEDI 14.1 38.0 35.5 10.2 2.3 27
DIGpSEpSTEDQAMEDI 31.5 31.2 22.1 16.7 0.7 29
VLVpTQQFPCQNPLPVNSGQAQ 0 59.2 21.2 17.8 1.8 40
QLQApTSVPHPVS 27.6 7.1 52.1 10.1 3.2 15
RpTpTLCGTLDYLPPEMIEG 13.0 21.6 39.3 26.1 0 27
ILSDVTHpSAVFGVPAS 0 33.6 60.6 5.8 0 27
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number of b ions (b6Δ, b7Δ, b11Δ, b15Δ). Pinpointing
phosphorylation sites in phosphopeptides on the observation
of species corresponding to the elimination of H3PO4 from
product ions has been recently questioned [23, 25], as a net
dissociation transition of 98 Da could be the result of
elimination of metaphosphoric acid (HPO3) from the
phosphorylation site and H2O from a non-modified serine
or threonine residue. In this particular example, CID of the
untreated phosphopeptide failed to generate product ions for
most of the N-terminal portion of the peptide, which serves
to decrease confidence in the phosphopeptide identification
compared with the treated peptide.
Very similar effects were seen for the peptide
VPQLEIVPNpSAEER, which undergoes extensive loss of
H3PO4 (m/z 781.8) as a result of CID (Figure 2a). The
analogous neutral loss species is almost completely
eliminated in the product ion mass spectrum of the CBP-B-
treated peptide (Figure 2b), thus confirming the anticipated
effect of the removal of the C-terminal basic residue on the
decreased prevalence of the neutral loss pathway.
An increased ion current towards diagnostic b and y ions
is of particular value in all those circumstances where
unambiguous identification of the peptide relies on the
detection of sequence specific product ions, as is the case for
SRM-based assays for phosphopeptide quantification [41].
The synthetic peptide ILSDVTHpSAVFGVPAS(K) was
chosen to investigate whether an internal basic residue such
as histidine, with a proton affinity (PA = 228.3 kcal/mol)
[26] lower than that of arginine and lysine, can limit the
benefits of the CBP-B treatment. This peptide demonstrated
very similar behavior indicating that the internal histidine
residue in this peptide does not have sufficient gas-phase
basicity to trap the proton and hinder the formation of b and
y ions, and confirms that the basicity of the proton ‘sink’
Figure 1. CID product ion mass spectra of (a) the doubly protonated peptide before (VLVpTQQFPCQNPLPVNSGQAQR; m/z
1280.7) and (b) triply protonated peptide after (VLVpTQQFPCQNPLPVNSGQAQ, m/z 802.2) CBP-B treatment, demonstrating
complete absence of neutral loss of phosphoric acid from the precursor and product ions following CBP-B treatment
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plays a major role in dictating the outcome of CID
(Supplementary Figure 1).
Of particular interest, therefore, are those peptides
characterized by the presence of a non C-terminal Lys or
Arg residue, generated either as a consequence of a missed
cleavage site or an internal [K/R]P, which does not undergo
trypsin proteolysis. The Aurora A phosphopeptide
RpTpTTLCGTLDYLPPEMIEG, which has an N-terminal
basic residue arising because of incomplete tryptic cleavage,
was observed as a doubly charged ion at m/z 1113.2
(Supplementary Figure 2) and generated an almost complete
series of b and y ions upon CID, allowing unambiguous
localization of the two phosphorylation sites at positions 2
and 3. The base peak in the product ion spectrum is the y7
ion, and no neutral loss of H3PO4 or (H3PO4 + H2O) could
be observed. Despite the presence of a basic residue (Arg at
position 1), the doubly charged ion is still under a MPE as
the extra proton can potentially relocate to any of the amidic
nitrogen atoms upon CID due to the lack of any other proton
‘sink’ within the peptide sequence, therefore balancing the
competition between potential dissociation pathways
towards dissociation of the amidic bond. An internal basic
side chain (Figure 3 and Supplementary Figure 3) can also
serve as a proton ‘sink’, meaning that even after CBP-B
treatment, doubly charged peptides are under a LPME, as the
number of basic residues (three) is greater than the number
of ionizing protons. Figure 3 compares the CID product ion
spectra of LVpSSHKPVQNQK before (Figure 3a) and after
(Figure 3b) treatment with CBP-B. In both cases, the product
ion mass spectrum is dominated by a base peak
Figure 2. CID product ion mass spectra of doubly protonated peptide: (a) before (VPQLEIVPNpSAEER, m/z 830.7) and (b) after
(VPQLEIVPNpSAEE, m/z 752.7) CBP-B treatment, demonstrating a significant reduction in the extent of neutral loss of
phosphoric acid following CBP-B treatment
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corresponding to the neutral loss of H3PO4 from the
precursor ion (m/z 673.7 and 609.7, respectively) with
limited formation of product ions. The internal lysine at
position 6 acts as a proton sink, potentially along with the
histidine residue at position 5, which is the second most
thermodynamically favored protonation site [26]. CBP-B
treatment of this peptide therefore has little effect on the
extent of loss of H3PO4 as a result of the limited mobility of
the ionizing protons and the occurrence of a hydrogen bond
between the internal lysine and the phosphate on Ser at
position 3, which is likely to facilitate the elimination of
H3PO4 in the treated phosphorylated peptide.
Gas-phase elimination of H3PO4 upon CBP-B treatment
can still be observed for some peptides that do not contain
an internal K/R residue, albeit at significantly reduced levels,
as for the case of QLQApTSVPHPVS (Supplementary
Figure 4). However, even under these circumstances, the
ion current associated with b and y ion formation (no
neutral loss) remains enhanced. Supplementary Figure 5
shows CID product ion mass spectra for the peptides
TVDMEpSTEVFTK (Supplementary Figure 5a),
TVDMEpSTEVFTKK (Supplementary Figure 5b) and
the CBP-B treated TVDMEpSTEVFT (Supp. Figure 5c)
respectively. The CID product ion mass spectra of the native
phosphopeptides both show base peaks corresponding to the
neutral loss product ions (m/z 733.6 and m/z 614.1,
respectively) which are markedly reduced in the CID product
ion mass spectrum of the corresponding CBP-B treated
Figure 3. CID product ion mass spectra of doubly protonated peptide: (a) before (LVpSSHKPVQNQK, m/z 722.7) and (b) after
(LVpSSHKPVQNQ, m/z 658.7) CBP-B treatment. The presence of an internal lysine residue (PA = 239.4 kcal/mol) overcomes the
benefits of the removal of the C-terminal lysine, forcing the system towards a reduced proton mobility and therefore favoring
the pathway leading to the neutral loss of H3PO4 over the dissociation of the amidic C–N bond
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peptide. Unambiguous assignment of the phosphorylation
site was not possible for the shorter native peptide, due to
the lack of sufficient diagnostic ions to safely discriminate
between phosphorylation of Ser6 and Thr7 (Supplementary
Figure 5a), although a minor product ion defined as y7 in
the longer peptide appears to localize the site of
modification to Thr7. Removal of the C-terminal lysine
residue(s) (Supplementary Figure 5c) resulted in the
generation of b6, b7, y5 and y6 product ions, enabling
confident localization of the phosphorylation site to position
6. These data therefore appear to imply a heterogeneous
population of Ser6 and Thr7 phosphopeptides in this
sample. The prominence of the different dissociation
pathways is particularly striking when considering the
product ions arising from the mis-cleaved peptide
TVDMEpSTEVFTKK, containing a dibasic C-terminus
(Supplementary Figure 5b). CID of this peptide generates
a product ion mass spectrum that is dominated by the
neutral loss fragment ion at m/z 748.8, with most of the
sequence-specific product ions being observed at very low
levels.
Peptide VLCPSNpSSQR yielded an interesting CID
product ion mass spectrum; although the peptide lacks an
obvious proton sink, the spectrum was dominated by neutral
loss of the precursor ion both before and after CBP-B
treatment (Supplementary Figure 6a and b). However, the
treated peptide showed additional b and y ions (y2 and y3)
which enabled unambiguous identification of the
phosphorylation site at position 7. For this peptide sequence,
the phosphorylated serine residue at position 7 is
characterized by the highest proton affinity (224.2 kcal/
mol) [27]. For the doubly charged precursor ion, the oxygen
of the phosphor-ester is likely to be the preferred protonation
site, meaning that the system contains a -CH2-O-PO3H2
moiety where protonation of one of the oxygens (which
normally requires the energy imparted to the ion upon CID)
is likely pre-existent to the fragmentation process.
Consequently, the species are much more labile towards
H3PO4 elimination, as the leaving group is already
preformed in the structure of the precursor ion.
Finally, it is worth noting one particular case where a
‘chimeric’ CID product ion mass spectrum was generated for
a pair of isomeric, co-eluting phosphorylated peptides after
CBP-B t rea tmen t : DIGSEpSTEDQAMEDI and
DIGpSESTEDQAMEDI at m/z 860.1 (Figure 4). The
tandem mass spectrum contains all of the product ions
required for confident localization of the phosphorylation
site on the serine residue in position 6. However, two
product ions, namely y10* and y11* at m/z 1138.4 and
1267.5, respectively, account for a phosphorylated serine at
position 4. The computational algorithms Mascot and
Ascore identified Ser6 and Ser4 as the phosphorylation site,
respectively. This contradiction in site localization highlights
a largely unaddressed issue of most of the automated search
algorithms which face considerable limitations when dealing
with chimeric tandem mass spectra generated from co-
isolation of isobaric species, and demonstrates how non-
rigorous interpretation of the output from automated search
engines might lead to incorrect inferences in site
localization.
CBP-B Treatment Increases the Number
and Intensity of Sequence-Specific b and y ions
To quantify the effects of CBP-B treatment on the
appearance of useful, diagnostic product ions, an in-house
R script was used to extrapolate ion currents associated with
the different product ion types, namely: precursor ion-
H3PO4; precursor ion-(H3PO4 + H2O); b ions (+1, +2); y
ions (+1, +2); (b ions-H3PO4) (+1, +2); (y ions-H3PO4) (+1,
+2); (b ions-H2O) (+1, +2); (b ions-NH3) (+1, +2); (y ions-
H2O) (+1, +2); (y ions-NH3) (+1, +2). Table 2 list the
intensities of these ions as percentages of the total product
ion current for each of the identified phosphorylated
Figure 4. CID product ion spectra of the doubly protonated peptide DIGSEpSTEDQAMEDI m/z 860.1 after CBP-B treatment.
Product ions specific to the co-eluting peptide DIGpSESTEDQAMEDI (y10 and y11) are highlighted in bold and italic
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peptides before and after removal of the C-terminal residue,
respectively.
The effects of the CBP-B treatment are particularly
noticeable when comparing the relative amounts of b ions
for the treated and untreated peptides. The percentage ion
current associated with intact b ions ([M + H]+ and [M +
2H]2+) is consistently higher for the treated peptides: up to
13 times greater in the case of TVDMEpSTEVFT(K).
Chawner et al. [37] already described how removal of the
C-terminal basic residue from unmodified tryptic peptides
has a marked influence on the distribution of CID and ETD
product ions, with an increased ion current of the b and c ion
series observed after the treatment, due to the mobilization
of the ionizing protons. Appearance of certain b ions was
only observed upon removal of the basic C-terminus,
leading the authors to hypothesize that not only does the
removal of C-terminus release the ionizing protons, but it
can also modify the gas-phase reactivity of the
corresponding ionic species. This allows them to enter
otherwise less accessible or inaccessible energetic pathways,
resulting in pronounced increase in the intensity of defined b
ions. A similar effect could account for the appearance of the
b7 and y6 ions in Figure 2a.
The signal due to neutral loss elimination of H3PO4 (with
or without concomitant elimination of H20) from the
precursor ion also decreases by an average of 26.3 %,
without taking into account those phosphorylated peptides
which could only be identified after CBP-B treatment.
Furthermore, it is interesting to note how even when the
extent of gas-phase neutral loss of H3PO4 from the precursor
ion is still the main channel of dissociation in the treated
peptide, there is an increased number of diagnostic b and y
p r oduc t i on s ; f o r e xamp l e , C ID o f pep t i d e
EQLSTpSEENS(K) generated 21 sequence specific b/y ions
after treatment, but only 9 ions before treatment
(Supplementary Figure 7), again allowing precise
localization of the phosphorylation site due to the
appearance specifically of the b6 and y5 ions. This confirms
what was presciently anticipated by Rožman [20] and
demonstrated by Chawner et al. [37]: by sequestering the
ionizing proton, the basic C-terminal residue effectively
controls the kinetic thermodynamic accessibility of several
dissociation pathways, ultimately dictating the appearance of
defined b and y ions.
CBP-B Improves Search Engine-Based Data
Analysis of CID Product Ion Mass Spectra
Having shown that removal of the C-basic residue results in
enhanced formation of sequence and phosphorylation site-
specific b and y ions, we investigated whether the better
quality of the CID product ion mass spectra could be
reflected in improved performance of the search engine
Mascot, by comparing the ion scores and expectation values
associated to the identified phosphorylated peptides before
and after the CBP-B treatment. Mascot delta (MD) score
[39] and Ascore [40] were further implemented to assess
whether our protocol could help with discriminating between
two potential candidate phosphorylated isoforms for those
peptides containing more than one potential site of
phosphorylation.
Mascot Delta is a search-engine difference score, which
relies on the difference in Mascot Ion score between the
top-and second-ranked peptide spectrum matches to
assess the reliability of the sequence identification and
site location. In contrast, Ascore is a probability-based
localizer which does not rely on scoring metrics but
rather applies its own scoring algorithm to the product
ion spectrum using the inferred phosphopeptide
identification generated by the search engine. The
Ascore algorithm only annotates intact phosphorylated
product ions [40] (i.e. product ions carrying the intact
phosphoester moiety) and makes use of an intensity-
based peak depth filter to maximize the annotated-to-
unannotated ion ratio.
Table 1 lists all of the phosphorylated peptides identified
in the untreated and treated peptide sets, correlating Mascot
ion scores, expectation values, MD scores and Ascore values
for the two sets of peptides. Under circumstances where the
same peptide was identified more than once, the CID
product ion mass spectrum associated with the highest score
was selected. Averaged ion scores, resulting from eight
technical replicates, are also provided. Apart from
VLVpTQQFPCQNPLPVNSGQAQ which appeared as a
triply, rather than a doubly charged ion after CBP-B
treatment, all comparisons were performed between
precursor ions of the same charge state. With the exception
of peptide FQpSEEQQQTEDELQDK (the score of which
decreased from 97 to 83), the highest ion scores of each
phosphopeptide were improved after removal of the C-
terminal residue. The average ion scores confirmed this
trend, with the CBP-B treated peptides all having scores
equal to or greater than their unmodified counterparts. The
average increase in ion score was 14.7, without taking into
account the four phosphopeptides which could only be
identified after CBP-B treatment. Tandem mass spectra
generated from these four phosphopeptides all yielded ion
scores above 30, with a maximum value of 74,
demonstrating the beneficial effects of enhanced formation
of product ions on the performance of the search engine.
Moreover, improved expectation values (sometimes by two
orders of magnitude) are associated with the treated set of
phosphorylated peptides, confirming that sequence
assignment of the modified peptides can be achieved with
greater confidence.
MD scores were also improved, especially for peptides
containingmore than one potential site of modification, as in the
case of peptides EQLSTpSEENSK, TVDMEpSTEVFTK(K),
VLCPpSNSSQR and VLVpTQQFPCQNPLPVNSGQAQR,
whose delta scores were increased by 6.1, 6.3, 16.4 and 15.6
respectively. For the first three phosphopeptides above, CBP-B
treatment increased the MD score above the cutoff value of 10,
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which approximates to a 5 % false localization rate on an ion-
trap instrument with CID fragmentation [39].
As the CBP-B treatment increases the number and relative
intensity of sequence specific b and y ions with no neutral loss,
the CID product ion mass spectra typically contain more peaks
likely to survive the filtering process required for Ascore. With
the exception of FQpSEEQQQTEDELQDK, (Supplementary
Figure 8), for which the Ascore value dropped from 137.1 to
84.9, the Ascore values for all of the other phosphorylated
peptides increased upon CBP-B treatment (Table 1) by an
average of 20.2. Unsurprisingly, the Ascore value of
LVpSSHKPVQNQK, whose CID product ion mass spectrum
was unaffected by the treatment, was unchanged. A remarkable
increase in the Ascore value was obtained for peptide
EQLSTpSEENSK, which went from 0 to 20.4, confirming that
the algorithm greatly benefits from the improved quality of the
CID product ion mass spectra.
Overall, computational phosphopeptide sequence
identification and phosphosite localization for this relatively
small dataset both benefitted (or were largely unchanged)
from this sample preparation step. However, it will be useful
to assess the effect of our protocol on the performance of
search engines with a much larger dataset prior to global
implementation of this strategy for high-throughput
phosphoproteomics studies. Irrespective, this procedure
seems to be of particular benefit when the appearance of
one or few diagnostic product ions is the limiting factor in
the possibility of distinguishing between potential
phosphorylated isomeric peptides with internal, sequential
Ser and Thr residues.
Conclusions
Enzymatic removal of the C-terminal basic residue from
tryptic and Lys-C phosphorylated peptides using CBP-B
resulted in the generation of species whose CID, as
performed with a Paul-type ion trap, showed reduced
elimination of phosphoric acid and enhanced formation of
sequence specific, diagnostic product ions. Removing the C-
terminal proton ‘sink’ from such phosphopeptides eliminates
the possibility for the charged C-terminus to promote the
H3PO4 loss, resulting in transition towards a more mobile
proton environment in which the competition between
neutral loss of phosphoric acid and cleavage of the C-N
amidic bond is thermodynamically more balanced. The result
is improved confidence in both sequence determination and
site localization. This strategy is particularly beneficial in those
cases where defining the exact location of the modification on
the peptide sequence is problematic (and oftentimes incorrect)
due to the presence of multiple potential phosphorylation sites
which may be clustered in a short region of the sequence.
Considering the role described for the C-terminal basic residue
in the gas-phase scrambling of the phosphorylation site [20,
25], removal of this residue may also limit the occurrence of
this phenomenon, which has been reported to affect the CID-
based analysis of phosphorylated peptides to differing extents
[25, 42].
The efficiency of CBP-B treatment for improving high-
throughput global phosphoproteomic analysis on a whole
cell lysate is hard to predict based on this necessarily limited
dataset for comprehensive analysis, and consideration will
need to be given to the database search strategies employed,
due in part to issues associated with defining the proteolytic
rules for CBP-B treatment on the database. However, our
current data indicates that this approach could indeed be
useful for more complex phosphoproteomics datasets given
firstly that the majority of peptides were converted to their
CBP-B analogues, and secondly that both the number of
phosphopeptides identified and the confidence in
phosphopeptide identification increased following CBP-B
treatment. Consequently, we envisage that this approach,
based on a simple enzymatic reaction performed
immediately after digestion of the target proteins that does
not require any additional sample clean-up, will be of
notable benefit in phosphopeptide analysis, particularly
when alternative, complementary dissociation strategies,
i.e. ETD/ECD, are not available. Ultimately, this study
provides experimental proof of the role played by basic
residues and charge distribution in the low-energy CID of
protonated, phosphorylated peptides, confirming the theory
which describes their gas-phase dissociation pathways.
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